CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Sr. VP & Corp. Secretary acquired 3,000 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 3,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Open-market buy Director bought 50,000 shares at an average $5.15 ($257,579)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 60,500 shares (option exercise)
- 4 Option exercise Sr VP/Chief Commercial Officer acquired 7,400 shares (option exercise)
- 4 Option exercise Director acquired 37,158 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,000 shares at $6.90 ($20,703)
- 4 Open-market buy Director bought 5,900 shares at $6.80 ($40,120)
Page 24 of 26 · 512 filings